An Open-Label Pilot Study of Pregnenolone in the Treatment of Individuals With Autism
Phase of Trial: Phase II
Latest Information Update: 03 Apr 2017
Price : $35 *
At a glance
- Drugs Pregnenolone (Primary)
- Indications Autistic disorder
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 03 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 13 Jan 2014 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 according to ClinicalTrial.gov.